Intellia Therapeutics, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Regulation FD Disclosure

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Other Events

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Automatic Shelf Registration

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Automatic Shelf Registration

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Clark Eliana

LEONARD JOHN M

LEONARD JOHN M

STATE STREET CORP

Dulac Edward J III

Dulac Edward J III

Dube Michael P

Dulac Edward J III

Goff Brian

Bhanji Muna

Cohen Fred E

Keresty Georgia

Verwiel Frank

CHASE WILLIAM J

GOODMAN JESSE

VANGUARD CAPITAL MANAGEMENT LLC

VANGUARD PORTFOLIO MANAGEMENT LLC

VANGUARD GROUP INC

Clark Eliana

Dube Michael P

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

No description available

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

No description available

No description available

Letter from the SEC

Post-effective amendment to an automatic shelf registration statement

Correspondence with the SEC

Letter from the SEC

No description available

No description available

No description available

No description available

Correspondence with the SEC